Nils Wellhausen

Harvard University — United States

Medicine · Health Sciences

14h-index1.2kcitations52works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(30), CRISPR and Genetic Engineering(15), SARS-CoV-2 and COVID-19 Research(11), Advanced biosensing and bioanalysis techniques(7), Immunotherapy and Immune Responses(6)

Publications50 total

Gene regulatory network analysis identifies dysregulation of hypoxia pathways as contributing to glioblastoma multiforme treatment resistance in females
2026Open Access
Dual-targeted ping-pong CAR T cells: Leveraging peripheral expansion to improve solid tumor immunotherapy
Proceedings of the National Academy of Sciences·2025Open Access
Lipid nanoparticle-mediated epitope editing in human HSPCs enables resistance to CD45-directed CAR-T cell therapy
Blood·2025Open Access
Ping-pong dual CAR T cells: antigen-specific peripheral expansion of dual-targeted CAR T cells boosts antitumor immunity against solid tumors 2126
The Journal of Immunology·2025Open Access
Microenvironmental regulation of solid tumour resistance to CAR T cell therapy
Nature reviews. Immunology·2025· 4 cited
An integrated enzymatic and computational pipeline for quantifying off-target base-editing
2025Open Access
Mutant KRAS peptide targeted CAR-T cells engineered for cancer therapy
Cancer Cell·2025· 14 cited
Quadruple adenine base–edited allogeneic CAR T cells outperform CRISPR/Cas9 nuclease–engineered T cells
Proceedings of the National Academy of Sciences·2025· 18 citedOpen Access
Selection for an HIV-Resistant Immune System By Multiplex Epitope Base-Edited CD45 CAR-T Cell Therapy
Transplantation and Cellular Therapy·2025
Base-Editing Human Hematopoietic Stem Cells to Enable Venetoclax Post-Transplant Maintenance Therapy for AML
Transplantation and Cellular Therapy·2025
Selection for an HIV-Resistant Immune System By Base-Edited CD45 CAR-T Cell Therapy
Blood·2024Open Access
CD45 threads the needle of cytokine cancer immunotherapy
Nature Immunology·2024· 2 cited
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Tables from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
Supplementary Figure 2 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024Open Access
page 1 of 3Next →

Frequent Co-authors

Carl H. June(29), Saar Gill(19), Sangya Agarwal(16), Nils W. Engel(14), Halie M. Rando(13), Ronan Lordan(13), Anthony Gitter(13), Casey S. Greene(13), Nathan Singh(12), Alexandra Lee(11), Joseph A. Fraietta(11), Regina M. Young(10), Elizabeth Sell(10), Adham S. Bear(10), Christian Brueffer(9), Ju-Fang Chang(9), Jack H. Landmann(9), Caitlin R. Hopkins(9), January Salas-McKee(9), Mehmet Emrah Selli(9)